Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.58 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.55 |
| ▸ | CASP2 | P42575 | 1/20 | 0.52 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.52 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.47 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.47 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.47 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.46 |
| ▸ | RRM1 | P23921 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9111268 | 0.98 | EPHX1 (0.61) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| SCHEMBL4066317 | 0.98 | EPHX1 (0.61) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| SCHEMBL5960404 | 0.98 | EPHX1 (0.61) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| SCHEMBL8962168 | 0.98 | EPHX1 (0.61) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| SCHEMBL8962332 | 0.98 | EPHX1 (0.61) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| SCHEMBL28983321 | 0.98 | EPHX1 (0.61) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| SCHEMBL7748456 | 0.98 | EPHX1 (0.61) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| SCHEMBL8962477 | 0.98 | EPHX1 (0.61) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| Ethane SCHEMBL28842141 | 0.96 | EPHX1 (0.59) | EPHX1DPP7CASP2PLA2G2AZDHHC20 | |
| Benzene SCHEMBL29129937 | 0.94 | EPHX1 (0.52) | EPHX1DPP7CASP2PLA2G2ANAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4293331-A | Novel acyloxamides and plant growth regulant compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | claimed |
| EP-0002455-B1 | ACYLOXYAMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR REGULATING THE GROWTH OF PLANTS | BAYER AG (DE) | 1980-11-26 | — | — | EP | claimed |
| EP-0002455-A1 | Acyloxyamides, process for their preparation and their use for regulating the growth of plants | BAYER AG (DE) | 1979-06-27 | — | — | EP | claimed |
| JP-54084520-A | — | — | None | — | — | JP | disclosed |
| CN-113271777-B | Compositions comprising clopyralid and other herbicides and methods thereof | 美国陶氏益农公司 | 2023-05-23 | — | — | CN | disclosed |
| US-20130224227-A1 | NOVEL CONJUGATES OF CC-1065 ANALOGS AND BIFUNCTIONAL LINKERS | BYONDIS B.V. (NL) | 2013-08-29 | — | — | US | disclosed |
| US-8067420-B2 | Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| US-8012984-B2 | Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-09-06 | — | — | US | disclosed |
| US-20110144060-A1 | SUBSTITUTED PYRAZINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS AND METHODS | BRISTOL-MYERS SQUIBB COMPANY | 2011-06-16 | — | — | US | disclosed |
| US-20110003759-A1 | NON-BASIC MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS AND METHODS | BRISTOL-MYERS SQUIBB COMPANY | 2011-01-06 | — | — | US | disclosed |
| EP-2173725-A2 | NON-BASIC MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS AND METHODS | Bristol-Myers Squibb Company (US) | 2010-04-14 | — | — | EP | disclosed |
| WO-1991013113-A1 | OXYGEN BARRIER | EXXON CHEMICAL PATENTS INC. (US) | 1991-09-05 | — | — | WO | disclosed |
| US-4293331-A | Novel acyloxamides and plant growth regulant compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | disclosed |
| US-4293331-A | Novel acyloxamides and plant growth regulant compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | disclosed |
| US-4293331-A | Novel acyloxamides and plant growth regulant compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | disclosed |
| EP-0002455-B1 | ACYLOXYAMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR REGULATING THE GROWTH OF PLANTS | BAYER AG (DE) | 1980-11-26 | — | — | EP | disclosed |
| US-4217348-A | Cephalosporins having an oxazolidonyloxamido substituted acyl sidechain | E. R. SQUIBB & SONS, INC. (US) | 1980-08-12 | — | — | US | disclosed |
| JP-S5484520-A | NOVEL ACYL OXAMIDE* ITS MANUFACTURE AND USE AS PLANT GROWTH REGULATING AGENT | BAYER AG | 1979-07-05 | — | — | JP | disclosed |
| EP-0002455-A1 | Acyloxyamides, process for their preparation and their use for regulating the growth of plants | BAYER AG (DE) | 1979-06-27 | — | — | EP | disclosed |
| EP-0002455-A1 | Acyloxyamides, process for their preparation and their use for regulating the growth of plants | BAYER AG (DE) | 1979-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144060-A1 | SUBSTITUTED PYRAZINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS AND METHODS | MCHR1, MC1R, MCHR2 | EPHX1 1391/4885DPP7 728/4885CASP2 4501/4885 |
| US-20110003759-A1 | NON-BASIC MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS AND METHODS | MCHR1, MCHR2, MC1R | EPHX1 1017/4885DPP7 1542/4885CASP2 4667/4885 |
| US-20130224227-A1 | NOVEL CONJUGATES OF CC-1065 ANALOGS AND BIFUNCTIONAL LINKERS | PCNA, DCLRE1A, CDC5L | EPHX1 2864/4885DPP7 2846/4885CASP2 1106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.